Withdrawal of Track and Trace System for Drug Export Formulations.
The Director General of Foreign Trade has officially withdrawn Para 2.76 from the Handbook of Procedures 2023, which previously outlined the procedure for implementing the Track and Trace system for export consignments of drug formulations.
This change means that the responsibility for implementing the authentication system for drug formulations being exported will now fall under the Ministry of Health and Family Welfare. The implementation will follow the provisions set forth in the Drug Rules of 1945.
This update comes into effect immediately. For more details, exporters should refer to the Ministry of Health and Family Welfare for guidance on the new process.
DGFT
Legal
Company Secretarial
DGFT Notifications
Others
Recent Posts
- Bombay High Court Rules: No Interest or Penalty on IGST for Past Imports under Advance Authorisation
- Advance Authorisation License Clubbing: A Complete 2025 Guide to New Rules, Benefits & Compliance
- Call for Feedback: Review of Automobile Tyre SIONs
- Revalidation and Extension of Export Obligation Period for Advance Authorisation License
- How to Procure Raw Materials Domestically Through ‘Advance Authorisation License’ Invalidation
- Government Extends IPL’s STE Status for Urea Import Until 2026.
- The “Free” import policy of Urad – Extended
- Government Extends Import Policy for Yellow Peas Until May 31, 2025.
FeATURED ARTICLES
Bombay High Court Rules No Interest or Penalty on IGST for Past Imports under Advance Authorisation In a landmark judgment,…
Advance Authorisation License Clubbing: A Complete 2025 Guide to New Rules, Benefits & Compliance The Advance Authorisation Scheme, governed by…
Call for Feedback: Review of Automobile Tyre SIONs The Directorate is currently reviewing the existing Standard Input Output Norms (SIONs)…
Revalidation and Extension of Export Obligation Period for Advance Authorisation License In the world of exports and imports, the Advance…
